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The Centre for Health Services Studies (CHSS) at the University of Kent is a centre of research 
excellence which undertakes high quality research into a wide range of health systems and 
health services issues at local, national and international levels. CHSS also supports and advises 
health care staff to develop and undertake research projects. CHSS collaborates with a wide 
range of partners in Kent, the UK and in other countries to improve the links between research, 
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Medical research is an indispensable part of the 
United Kingdom’s national identity. From the 
world’s first vaccine to the world’s first bionic 
hand, innovations in healthcare have played an 
integral part in shaping the UK’s international 
status and contribution to humankind. When 
the UK invests in medical research it delivers 
improvements to patient care, develops the 
skills of our health service staff, and drives 
economic growth through innovation. 
People are at the heart of driving this 
innovation – researchers in industry, academia 
and the NHS working together and playing 
critical roles in leading and delivering research. 
Never has this been needed more. Faced with a 
global pandemic and pressures on frontline 
care, researchers worked together to rapidly 
recruit patients onto COVID-19 studies and 
discover that Dexamethasone can significantly 
reduce mortality from COVID-19 – a world first.  
Although this achievement has been deservedly 
applauded across the globe, its publicity masks 
systemic and persistent obstacles in the UK’s 
health system that make these 
accomplishments exceptional case studies, 
rather than the norm. It’s therefore essential 
that we learn from COVID-19 and expand on 
programmes like the Life Sciences Industrial 
Strategy (LSIS) to build a stronger UK research 
ecosystem.  
The NHS is an integral part of this ecosystem. It 
makes a unique contribution to the UK’s global 
status as a world leader in health, and it 
provides the foundation for medical research’s 
ambitious future. Yet for many NHS staff, 
research is presented as an over-bearing add 
on, despite studies showing participation in 
research improves staff retention and morale.  
This weak research culture has made research 
inaccessible for many NHS professions, 
particularly nurses, midwives, and Allied Health 
Professionals. Even professions with research 
experience, such as doctors, face difficulties 
accessing dedicated research time and funding, 
forcing some to conduct research using annual 
leave at their own expense. Research is 
particularly inaccessible for NHS Trusts that lack 
adequate research facilities and expertise, as 
this makes it difficult to hire experienced 
researchers and secure funding in competition 
with research-experienced NHS Trusts.  
These barriers to research predate COVID-19, 
but the pandemic has exacerbated them by 
placing severe pressure on research staff, 
infrastructure and funding. Previous efforts like 
the LSIS have attempted to overcome these 
obstacles, but they’ve been marred by 
disconnects between ambitious national 
strategies and the reality on the ground. This 
report bridges that gap. It builds on successful 
initiatives, such as the Pathways to Portfolio 
programme, to detail an actionable policy 
agenda that comprehensively addresses the 
barriers to expanding NHS research. Achieving 
this will require a truly cross-sector effort, with 
collaboration across all four nations in tandem 
with the NHS, universities, industry and medical 
research charities.  
The challenge is great, but the rewards are 
greater. Expand the NHS’s ability to conduct 
life-saving research. Make research truly 








Baroness Blackwood of North Oxford  
Former Minister of Innovation 
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Clinical research is at the heart of driving improvements for patients, developing new ways to 
prevent, diagnose and treat disease. There is growing evidence that patients treated in 
research-active hospitals get better quality care, even if they are not taking part in research.1,2 
Conducting research also has significant system-wide benefits beyond improving patient 
outcomes, including greater staff retention and financial benefits to the health system through 
commercial revenue.3,4 Clinical research is a historic strength of the UK, with one of the 
strongest health and life science industries in the world. This status has recently been 
enhanced,  through the leading role the UK has played in developing COVID-19 treatments and 
vaccines.5,6 Despite this success, we cannot rest on our laurels in an increasingly competitive 
global R&D economy; we must go further and faster.  
Improving our capacity and capabilities in clinical research is central to ambitious visions like 
the UK’s Life Sciences Industrial Strategy (LSIS). Capitalising on this area of strength will be 
critical to achieving broader Government ambitions for the UK to be a global science 
superpower as we forge a new future outside of the European Union.7  
However, while we can point to successes in areas such as COVID-19 research and learn from 
these experiences, they mask fundamental barriers to research in the UK that existed before 
the pandemic. Evidence over many years shows that a lack of time and capacity for healthcare 
staff to conduct or participate in research significantly holds us back.8 NHS staff report having 
insufficient time, funding and skills support to undertake research; inadequate organisational 
support for research; and limited opportunities to engage with research.9,10 Staff even report 
having to take annual leave to conduct research and funders report finding it harder to set up 
and run clinical trials. Pressure on time is only increasing as clinical trials become ever more 
complex due to advances in scientific understanding11,12 and persistent staff shortages across 
the health service.13 
Cancer Research UK commissioned this study on behalf of the medical research sector to 
identify solutions to these fundamental issues. This study offers a system-wide approach to 
improve capacity for clinical research in a breadth of research settings, professional groups – 
including doctors, nurses, midwives and allied health professionals – and disease areas. 
Addressing chronic staff shortages in the NHS is a critical issue, one that requires a sustained 
and comprehensive response. There are many excellent examples of good practice we can 
learn from in order to shift NHS research from separate siloes of activity to a cohesive, 
networked system of collaborative research. 
The pandemic has led to greater public recognition of the importance of research alongside 
innovations in how research can be conducted.14,15 This provides an unprecedented 
opportunity for a paradigm shift, where research is no longer seen as an ‘add on’ but fully 
integrated into the psyche of how the UK delivers healthcare. This report strives to achieve this 
ambition by informing new strategies to tackle persistent barriers to research, bridging the gap 
between national ambition and local practice, and driving forward a new era of research in the 





There is no shortage of policies, strategies and initiatives nationally and locally within health 
care organisations aiming to overcome barriers to research. These strategies are welcome, and 
were frequently endorsed by our interviewees and survey respondents. However, concerns 
were raised about the poor implementation of these strategies and lack of co-ordination 
between policy and practice. Long-term and significant capacity building requires a 
comprehensive and integrated package of policies, which combat the disconnect between 
national strategies and local practice. In this report we explore the issues and make 
recommendations for their improvement across four broad themes, at both the national UK 
and Devolved Government and local NHS organisational level. While R&D Offices are the 
natural home for many of these recommendations, it is vital they are implemented with the 
support of the entire NHS organisation they sit within. Our core recommendations are outlined 
in the executive summary, with our further recommendations presented in the body of the 
report.  
Dedicated research time is too inaccessible and inadequately 
supplied, meaning many staff conduct research in their own time 
and at their own expense. In our survey, ‘high demands of clinical 
services’ and ‘no protected time for research’ were the most 
cited barriers across all professions. Increasing research 
capacity can only go so far without addressing this underpinning 
limitation. This issue is exacerbated by a lack of visibility of 
research support schemes; with opportunities communicated 
to staff who are already research active. 
Funding must be increased to finance research itself and the time 
needed to carry out research through 
backfilling research-engaged roles. Study 
participants at all levels called for more financial support. The way 
existing research funding is allocated must also be improved to 
become more accessible to non-research active organisations.  
Due to their role in funding NHS-based research, the National 
Institute for Health Research, Chief Scientist Office, Health and 
Care Research Wales, and Health and Social Care Research and 
Development Division would be ideal vehicles for increased R&D 
investment by the UK Government and Devolved Administrations.   
Key recommendations:  
• In-line with the Academy of Medical Sciences' proposals, the UK 
Government and Devolved Administrations should implement fully funded 
pilot programmes that offer a proportion of health service staff (including those in 
under-represented professions) contracts that include dedicated time for research. 
• The UK Government and Devolved Administrations should uplift long-term funding for 
the NIHR, CSO, HCRW and HSC R&D. At a minimum, these funding increases should be 
in-line with broader uplifts in public R&D investment and keep pace with future 
increases in inflation. 
 
“They say ‘oh, it's really good, because 
you're building the profile of the 
hospital up’, but you don't get 
protected time for it. So, say I need to 
spend a day in a conference and I 
have to travel…when I come back I 
have to catch up with all my work. I 
take it as annual leave that’s how I get 
round it. But then you know, to use 
half your annual leave up to promote 
your hospital and your work, is a little 
bit cheeky.” – Nurse 
 
 
Good practice examples: 
✓ Research time provided through 
country specific fellowship 
schemes, supported by mentoring 
and support through a local 
university research centre  
✓ Sponsorship through charitable 
funds and providing tasters to teams 
as part of an uplift cycle: particular 
areas targeted by Trust by offering 







• NHS Trusts and Health Boards should increase the visibility and accessibility of 
dedicated time for research in order to expand research engagement amongst staff, 
especially under-represented professions. Progress towards this goal should be locally 
monitored using the research metrics and reviews we also recommend, as well as 
periodically reviewed by national NHS bodies.  
 
Persistent regional disparities in research funding, infrastructure and 
expertise exist, both within and between the UK nations. These disparities 
lead to regional variation in investment, professional development, and 
opportunities for patients to participate in research. Staff from less 
research-active Trusts or Health Boards were more likely to report 
experiencing barriers such as lack of time, limited research culture, and 
lack of confidence.  
There is substantial variation in research engagement between health 
service staff. Nurses, midwives and allied health professionals are 
particularly under-supported and under-represented. 
These professions aren’t an exhaustive list of who is under-
represented, but their experiences reflect wider disparities in 
research engagement. When these professions successfully 
participate in research, their value and contribution is less well 
recognised, and they suffer from lack of access to research 
infrastructure and support.  
Similarly, disparities in research opportunities between 
specialties must be addressed to increase capacity across the 
breadth of the health service. Each specialty faces unique barriers 
to improving research capacity, so improved monitoring of resource 
distribution and research activity is needed.  
Key recommendations: 
• The UK Government should conduct a regional review of clinical research activity. The 
review's findings should inform proposals for additional funding that facilitates 
increased research engagement within regions currently under-served by research. The 
review's findings should also inform revisions to existing R&D investment, with a view 
to making this investment more regionally equitable and unlocking research capacity. 
• Local NHS R&D Offices and Human Resources departments should collaboratively 
consult under-represented professions to identify and address the social and cultural 
barriers they face to engaging with research. Progress towards this goal should be 
locally monitored using the research metrics and reviews we also recommend, as well 
as periodically reviewed by national NHS bodies. 
 
“Depending on whether you 
are a clinician or AHP or 
Nurse or any other 
professional, the funding is 
disproportionately skewed 
to doctors rather than 
anyone lower on the food 
chain.” – AHP Lead 
 
 
Good practice examples: 
✓ Building partnerships between 
research-active and smaller Trusts  
✓ The 70@70 NIHR Senior Nurse 
and Midwife Research Leader 
Programme as an initiative 
specifically aimed at nurses and 
midwives raising research 
awareness, understanding, 




While variations exist, all staff can experience barriers on the pathway to building research into 
their career. One-off opportunities to get involved in research are not enough; resources and 
support must be applied continuously along health professional career pathways, enabling 
research capacity to be developed cumulatively.   
Insufficient research training and lack of research knowledge and skills is 
one of the top barriers for health service staff; 85% of survey 
respondents felt that training would support health service staff to 
be more research active. A long-term approach to research is 
needed to facilitate early and continued research exposure. 
Confidence, capacity and experience of staff to conduct research 
can be developed through small-scale research projects and 
sustained exposure to research 
throughout the career pathway.  
Research must not be seen and 
treated as a one-size-fits-all system. 
There are many diverse ways in 
which to get involved with and conduct research, and staff 
have a range of motivations for engaging with research, all of 
which requires different support. The top motivations were 
the same among both research-active and non-research-
active staff: to improve patient experience and outcome, 
personal interest in the research topic, and opportunity to 
continue learning. Understanding what makes staff want to get 
involved in research should be used for a basis for action. 
Key recommendations: 
• The NIHR, CSO and HSC R&D should develop new programmes modelled on the HCRW's 
Pathway to Portfolio Development Funding Scheme to fund small-scale projects that 
develop the confidence, expertise and capacity of NHS staff to deliver research. 
• NHS Trusts and Health Boards should embed research into their strategies for staff 
recruitment and retention, and workforce development planning. These local efforts 
should be reinforced by ambitious national strategies for supporting clinical research 
that recognise the NHS as an indispensable part of the UK’s research environment. 
 
Good practice examples: 
✓ Pathway to Portfolio Development 
Funding Scheme open to all healthcare 
staff in Wales to fund small-scale 
research scoping projects that will 
develop research skills such as grant-
writing, research question design, and 
community engagement. 
✓ Including research, audit, and quality 
of care improvement in job 
descriptions and work plans to raise 
research’s profile amongst staff, 
including middle managers. 
 
 
“When I finished my PhD fellowship 
and was going to come back to my 
NHS post, there was no job for me. So 
I ended up jobless for almost four 
months before I got back into an NHS 
post, and in there they didn’t 
recognise my increments, because I 
was in an academic post, although I 
was working all that time in the NHS. I 
actually took a pay cut to go back to 




In a strong research culture, research is valued, normalised and supported through connected 
bottom-up and top-down approaches. Research’s value must also be recognised 
at the societal, organisational, team and individual level. The actions set out 
above will in themselves contribute to building a stronger research 
culture. However, there are also actions which can be taken now to 
support the development of this culture.  
Research must be better connected to practice, with 
better illustration of the impact of research on 
patient care. There are insufficient metrics and 
processes to capture, report and communicate 
the value of research, in all its diverse forms. 
These should be based around what is important to 
staff, the service and patients: the impact and value in terms of 
patient experience, outcomes and perceptions; staff morale, 
development and retention; systems improvements and potential 
cost savings. Welcome progress has been made, such as inclusion of 
research in the Care Quality Commission well-led framework,16 but this 
must be built upon.  
Siloed research cultures create boundaries within and between organisations, hindering their 
ability to explore different perspectives, gain new insight, and pool resources in collaboration 
across sectors and institutions. There is widespread support for addressing this; 82% of survey 
respondents stated that closer ties with local academic organisations or industry would 
increase staff’s research activity.  
Key recommendations: 
• All four national departments of health should develop a coordinated set of metrics to 
capture NHS research engagement and impact. These quantitative metrics should 
capture research's impact on patients, staff, NHS systems and cost savings. The resulting 
data should be incorporated into existing platforms for evaluating NHS Trusts and 
Health Boards. 
• Local NHS R&D Offices should undertake periodic reviews of research awareness and 
activity amongst their health service staff and patients. The resulting qualitative insights 
should inform local efforts to showcase research's value and increase staff engagement 
with research. 
 
It is well known that more time and more funding for research is needed. Supporting this is 
vital, but in isolation will be insufficient. There is no one size fits all approach to increasing 
capacity. We must ensure that capacity-building initiatives benefit all health service staff, 
regardless of geography, profession or specialty. Staff at all stages of the career pathway must 
be supported to get engaged in research, in a consistent and cumulative way. These actions 
will contribute to building a strong research culture, where research in all forms is valued, all 
 
Good practice examples: 
✓ Using annual activity reviews 
of funded researchers to 
quantify and assess the quality 
of their contribution using 
locally developed metrics.  
✓ Collaborations between Trusts 
and universities to deliver 
placements for nursing 
students within research nurse 
teams. 
 
“There’s only so many hours 
in the day, and when you’re 
being pulled in every 
direction, something that 
requires you to sit down and 
think about how you’re going 
to tackle it goes to the bottom 




staff have the opportunity to get involved in research and all staff are research aware; an 
environment which will further promote, prioritise and support research.  
The report outlines four key themes, but none of these actions can overcome persisting barriers 
and build research capacity without emphasising the interconnected nature across policies 
recommended here and elsewhere across the sector. Better strategic coordination is needed 
at all levels, and this interconnected response must be overseen by a body with a clear mandate 
for monitoring the implementation of each individual policy by its respective body (Figure 1).  
DHSC and the Devolved Administrations should be given responsibility for ensuring this report's 
recommendations are implemented as an integrated package of policy solutions to the 
systemic challenges afflicting NHS research. 
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Over the last decade there has been a growing emphasis on increasing health service staff 
capacity to support, undertake and use research. The importance of research has never been 
more publicly recognised than in the COVID-19 pandemic, with research funders, industry, 
academia and the NHS all working collaboratively to develop treatments and vaccines. Globally, 
the UK has one of the strongest and most productive life sciences sectors in the world.17,18,19 
Yet despite this success, structural problems in developing and sustaining research capacity in 
NHS organisations persist.3,19,23 
The UK Research & Development (R&D) Roadmap highlights the importance of creating 
opportunities for people to develop their skills and experience in order to address the lack of 
research capacity amongst health care staff.24 The UK Government has committed itself to 
developing a comprehensive new R&D People and Culture strategy that includes supporting 
research.25 These ambitions are also reflected in the new NHS England People Plan and in 
Devolved Administration policies, such as NHS Wales’ research delivery framework. These 
emphasise the role research plays in improving and delivering good quality care, as well as 
aiding staff recruitment, development and retention. 
These latest strategies build on earlier initiatives and policies developed by the UK Government, 
Devolved Administrations, research funders, and professional bodies.2630 Successive policies 
have sought to increase life sciences research and NHS research activity by improving R&D 
infrastructure and supporting the development of research careers. However, while initiatives 
have been developed for 20 years or more, the impact has been variable with many studies 
questioning their effectiveness.31,32,33,34,35 Key problems persist in relation to inequalities in 
funding and opportunity, variation in where studies are undertaken and their subject matter, 
and a lack of coordination between policy and practice.  If these new strategies and policies are 
to have an impact, we need to understand why previous initiatives have failed and what needs 
to be done differently in order to expand the NHS’s research capacity.  
 
The benefits of research have been demonstrated at a national, local and individual level 
(Figure 2), which has led the Government to designate life sciences research as a key element 
of its industrial strategy.19 Building the research capacity of health professionals and supporting 
their involvement in research is therefore central to the UK and Devolved Administrations’ 









Figure 2: The benefits of research  
Economic benefits 
The UK life sciences sector is seen as a 
significant contributor to the economy and 
the NHS provides a unique institutional 
framework for health-related 
research.36,37 Studies have shown that 
there is a national economic benefit 
derived from medical research with public 
investment, which attracts additional 
private investment benefits to the overall 
economy.19,38 For example, £1 invested in 
medical research generates 25p in 
additional value to the economy, 
alongside the patient benefit of 
improvements to healthcare.39  
Benefits to patients 
There is clear evidence of patient benefit 
from research, as shown by the PARROT 
trial, and the response to the urgent need 
for research on COVID-19 has highlighted 
the NHS’ essential role in delivering clinical 
research, as well as long-term limitations 
on its capacity to fulfil that role.40,41 
Research provides both organisational and 
patient benefits through supporting 
service changes, such as service 
evaluations which assess service quality. 
There is a positive relationship between 
the amount of research undertaken in Trusts/Health Boards and lower mortality rates.3,20  
 
Examples of research’s patient benefits 
In the PARROT trial NIHR-funded researchers 
demonstrated that a blood test for pre-
eclampsia could reduce the time pregnant 
women wait for a diagnosis from 4.1 days to 
1.9 days, reducing their risk of serious health 
problems. The results were chosen as a rapid 
uptake product by the accelerated access 
collaborative so it was recommended by NHS 
England very quickly and there is evidence 
that it is in use.40  
The RECOVERY Trial is a large range of 
suggested treatments for COVID-19. 
Conducted by researchers at Oxford 
University, the ongoing Randomised 
Evaluation of Covid-19 Therapy (RECOVERY) 
trial involves all major hospitals in the UK on 
an unprecedented scale and as many as 3500 
doctors, nurses, and research staff, including 
consultants, junior doctors, and those newly 
graduated. Within its first three months it 
reported its first policy changing result: that 
the widely promoted antimalarial drug 
hydroxychloroquine was ineffective. This was 
swiftly followed by the announcement that 
dexamethasone is an effective treatment.41 
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Benefits to healthcare organisations and staff 
The role of research in improving service changes and provision of care benefits healthcare 
organisations; research-active organisations achieve better Care Quality Commission (CQC) 
ratings.20   
Impactful research is reliant on involving health service staff who can translate their day-to-day 
clinical experiences into research designs that deliver improvements to healthcare processes, 
performance and the quality of patient care.42,43,44,45,46,47,48 Recruitment and retention remain 
significant concerns for UK health providers, which participation in research can support. 
Health professional engagement can also enhance job satisfaction and professional 
confidence, with improved staff recruitment and retention helping to build and retain clinical 
expertise and improve patient care.44 Active engagement also contributes to improved staff 
attitudes towards research.49  
Increasing research activity and health service staff capacity to become involved in research 
should be a priority for all NHS organisations, not just those associated with universities or 
established research reputations.  
 
The NHS is undertaking more research than ever before, with 50% of NHS trusts increasing their 
research activity during 2018/19.50 Despite this increase, there remain significant variations 
between regions, specialties and types of healthcare organisation, with many healthcare 
professions – such as nurses, midwives and allied health professions (AHPs) – reporting 
significant barriers to engaging in clinical research.21,26,35,51,52 This increase in research also 
comes with increasing complexity, requiring additional resource to support activity.53,54 
Previous studies and surveys have identified a wide range of barriers to involving health 
professionals in research. Barriers stem from national priorities, funding, NHS organisational 
issues, relationships with academia, under-representation in research driven by systemic 
sexism and racism, disciplinary and professional inequalities, and individual 
opportunities.3,55,56,57 Barriers to research include: 
• Lack of time, funding or skills support to enable health professionals to undertake 
research; 
• Disparities in opportunities to develop research careers between different regions, 
professions, specialties, genders, and different ethnic groups; 
• Lack of research expertise and training, particularly among nurses, midwives and AHPs; 
• Lack of communication of research’s role in improving the quality and safety of 
healthcare, patient experience, and patient outcomes; 
• Lack of organisational support; and 
• De-prioritisation of research. 
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If the aspirations of government policy, research funders, health care organisations and of 
patients are to be met, it is essential we understand why such barriers persist and why efforts 
to address them fall short.  
Recent reports have suggested that the barriers to increased research activity persist due to 
competing priorities, NHS organisational issues and inequalities in funding, training, support, 
and opportunities to participate in research.3,58,59 However, whilst many of these studies 
provide useful insight into the drivers of NHS research activity, they frequently lack analysis of 
the entire NHS research system, which includes a diverse array of healthcare organisations, 
professions, specialties, government agencies, research funders, and health service staff.  
This study, therefore, considers enhancing health service staff research involvement and 
building research capacity from a systems perspective. Rather than focusing on bolstering 
research within a specific specialty or profession, this report considers how all components of 
the UK research ecosystem (policy, funding, training, academia, healthcare organisations, 
government bodies) can be used more cohesively to increase health service staff’s research 
activity.  
In taking a system-based approach to addressing research capacity, we explored system-wide, 
organisational, team and individual level factors (macro, meso and micro levels) and built on 
the framework for research capacity development developed by Gee and Cooke.60,61,62,63,64,65 
We drew on this to consider developing and supporting health service staff research 
engagement at these different levels to ensure our policy analysis and recommendations 




This report examines how the NHS, health care funders, national professional bodies and 
individual NHS Trusts/Health Boards can increase capacity of health professionals to support 
and conduct research. The study was commissioned by Cancer Research UK to “identify the 
scale of the challenge associated with health service staff lack of capacity to conduct research, 
then identify practical policy solutions to improve and boost capacity of the existing workforce 
to conduct research.” This includes not just the capacity of staff undertaking research (as 
research leaders or as team members), but also staff who may support research through 
patient recruitment, provide support services to studies, or those who use research findings 
in their clinical work. 
Our concept of health service staff research capacity is rooted in definitions of general 
research capacity. For this study we were interested in interventions operationalised through 
a range of levels to support health care staff’s ability to carry out research or achieve 
objectives in the field of research over the long-term.64 While we recognised that many types 
of health care organisations and staff are engaged in research this study was limited to NHS 
organisations and staff in the UK. 
Our definition of research concentrates on research directly impacting patients, including 
clinical research and research that harnesses existing patient data.  
The aim of the study was to identify the scale of the challenge associated with the lack of 
capacity, then identify practical policy solutions to improve and boost capacity of the existing 
workforce to conduct research.  
Our objectives were to:  
• Examine the scale of, and reasons for, organisational and structural factors which are 
associated with health service staff lacking capacity to conduct clinical research.  
• Identify examples of initiatives aimed at facilitating capacity to conduct clinical research 
including:  
o Ways of working that encourage and support a greater level of research; 
o Organisational factors that support a greater level of research; and 
o System factors that support and sustain a greater level of research. 
• Develop recommendations for policy and practice. 
This report presents the findings from this more holistic approach and identifies policy solutions 
for organisations, funders and policy makers. These aim to support the NHS and Departments 
of Health and Social Care across the UK and funding agencies in policymaking on optimising the 




Whereas previous studies have focused on specific sectors or professional groups, we took a 
system-wide approach, acknowledging that research capacity is a cross-cutting issue. This study 
is UK-wide, and the scope includes:   
• Public, charity and industry funders of research 
• Staff from a wide range of health care professions and specialties 
• Staff of varying levels of research activity and engagement 
• National service and professional bodies, research support and infrastructure 
organisations 




Building on the findings of previous studies on research engagement, we undertook a mixed-
methods study to examine how to support, enhance and sustain health practitioner 
research engagement.66 This explicitly involved collecting data at the micro (individual staff 
member/researcher), meso (organisational) and macro (system/policy) levels. Our 
approach also involved secondary data analysis, interviews and survey data in five 
interlinked work packages as shown in Figure 3:   
Figure 3: Study work packages 
 
Work-package one: Scoping review of the evidence and knowledge on research engagement 
support in health care organisations.67,68 The aim was to identify the current extent of 
knowledge about initiatives/interventions/policies that support successful research 
engagement. We reviewed key published studies and interviewed 12 key informants from 
across the UK including research staff, funders, regulators and research support infrastructure 
roles. 
Work-package two: Analysis of secondary data on research activity. The aim of this work-
package was to obtain an overview of research activity by organisation and staff 
group/speciality to help provide a national picture of activity and to help identify locations for 
work-packages three and four.  
Work-package three: Survey of research active and research non-active staff in health care 
providers. The aim of the survey was to identify the views of health service staff on issues 
related to what enables them to become more involved in clinical research, with a specific focus 
on what drivers and incentives support research activity and capacity. Survey questions were 
developed based on data from interviews with 14 research funder representatives and 25 R&D 
directors and leads, combined with data from Work-package one. We surveyed staff from 
different professional groups, specialities, current research activity in 11 NHS health care 
providers across the UK. Survey locations were selected in discussion between the research 
team and the Steering Group.  In total we received over 1200 responses (see Appendix 1 for 
full details of the survey and Supplementary Survey Report).  
Work-package four: Case study research in selected health care providers. The aim of the case 
studies was to gain an in-depth understanding of the context at an individual and organisational 
level of initiatives to support health service staff engagement in research.69 We interviewed 51 
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staff in six NHS Trusts/Health Boards in four countries (3 in England, 1 in Wales, 1 in Scotland 
and 1 in Northern Ireland). (See Appendix 1 for more details). 
Work-package five: Assessment and prioritisation of interventions.70 The aim of this phase of 
the research was to assess actions identified throughout the research that potentially could 
increase health professional involvement in research. The identified initiatives were assessed 
through a prioritisation process with the Steering Group to develop policy recommendations.  
Our methods ensured that we obtained a holistic view of the factors affecting healthcare 
professionals research engagement and contextualised understandings from a range of 
organisational and stakeholder perspectives at a national, local and organisational levels staff 
working in healthcare organisations. We surveyed a wide array of staff, including nurses, 
midwives, doctors, AHPs, healthcare scientists, and decisionmakers such as directors and 
professional leads. They were working in NHS acute and community health providers of varying 
size, type (teaching and non-teaching), acute and community and geographically spread across 
the UK. We interviewed stakeholders from across the UK and from research and non-research 
active groups of staff, funders, regulators and research support infrastructure roles, which 
contributes to the theory application.66,69 We conducted the scoping interviews by telephone 
and the case study interviews through a mixture of face to face and telephone interviews. All 
interviews applied a semi-structured interview approach and were audio recorded. We applied 
framework analysis for interview data from WP1 and WP3, and thematic analysis for case study 
interviews from WP4.71-74 The interview topic guides and analysis framework focused on key 
areas of motivation and research culture; challenges for healthcare staff at various career 
stages; funding; and operationalising strategies (Appendix 2 and 3).  
We worked closely with Cancer Research UK and the members of our Steering Group. Members 
of the Steering Group were drawn from the NHS, academia, departments of health and social 
care, professional bodies, health regulators and research funders to ensure that each element 
of the data collection fully addressed our research objectives and contributed to achieving 
actionable policy recommendations. This included reviewing our full range of evidence, survey 
and interview findings to develop our key recommendations, and inputting into the 
prioritisation of policy recommendations. The research methods are detailed more fully in 





From our scoping review, survey and interviews, we identified four recurring themes that 
impact research capacity and require policy responses. These were to: 
• Support staff and resource research infrastructure on a practical level, through investment 
in dedicated research time and facilities. 
• Target variations in research activity and capacity of staff, which exist across regions, 
professions and specialties. 
• Develop pathways to research, where opportunities to conduct and improve research 
capacity should exist for staff at all career stages, along the career pathway in a cumulative 
way rather than as one-off opportunities. 
• Strengthen national and organisational-level research culture to create an environment 
where research is valued, normalised and supported through connected bottom-up and 
top-down approaches. 
Many of the issues we identified have been highlighted in previous work concerning the 
barriers to health service staff’s engagement in research, reflecting the persistent and 
entrenched nature of these barriers. Our findings also support recommendations made in other 
reports such as those by the Academy of Medical Sciences22 and the Royal College of 
Physicians.3 Our interviewees and survey respondents frequently endorsed many existing 
policy responses to these barriers. However, they raised concerns over their poor 
implementation and lack of co-ordination between policy and practice. As one Associate 
Director of Research and Development from a national funder reflected: 
“In fairness, there is an acknowledgement to want to develop a workforce who want 
to learn and innovate – however, this is not sufficiently linked to the reality on the 
ground.”   
There is no shortage of policies, strategies and initiatives nationally and locally within health 
care organisations. However, the persistent findings in studies of barriers and lack of research 
engagement by staff clearly point to a problem of implementation. This disconnect is illustrated 































Long-term and significant capacity building can only be achieved if a comprehensive and 
integrated package of policies is introduced and implemented. Overarching responsibility for 
implementing these initiatives should fall to a clearly defined network of organisations that 
understand the interconnectedness of the research pathway and how competing priorities and 





Barriers to expanding research capacity are interconnected and varied. Yet underpinning 
cultural barriers, research disparities and limited pathways (which will be explored in themes 
2-4) is a widespread scarcity of research time and funding. Limited access to allocated research 
time forces too many staff to conduct research in their own time, sometimes at their own 
expense, and in turn increases the opportunity cost clinicians face when considering research 
engagement. Likewise, scarce funding restricts the number of research projects staff can 
participate in, thereby limiting the opportunities for staff to develop research experience, skills 
and capacity. 
These material constraints create a tangible limit to how far research capacity can expand, and 
they must therefore be urgently addressed. Achieving this requires a significant expansion in 
We recommend DHSC and the Devolved Administrations should be given responsibility for 
ensuring this report's recommendations are implemented as an integrated package of 





access to dedicated time for research, funding uplifts for key research funders and a review of 










Access to time for research, specifically allotted time free of immediate clinical tasks, was cited 
by interviewees and survey respondents as an essential driver of NHS research. A lack of 
allocated time can be caused by a variety of factors at every level of the health service (Figure 
5).  
Figure 5: Overview of issues impacting time for research 
 
A key barrier to research is pressure on staff time caused by high caseloads and limited clinical 
capacity, with one R&D manager noting: 
“We’ve got winter pressures, we’ve now Coronavirus…So, ultimately, this I suppose 
is where it does feel like research is the add-on…there is no way of backfilling, it’s just 





Key messages: Theme One 
• Dedicated research time is too inaccessible and too inadequately supplied, forcing 
many health service staff to conduct research activity in their own time and even at 
their own expense; this is unsustainable. 
• To backfill dedicated time and finance research, funding must be increased, especially 
for organisations that enable NHS research such as the NIHR, CSO, HCRW and HSC 
R&D. 
• The way existing research funding is allocated must also be improved, with a view to 
making it more accessible to non-research active healthcare organisations. 
In our survey, ‘high demands of clinical services’ and ‘no protected time for research’ were 
the most frequently selected barriers to research across each professional category. 
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 There were disparities between professions, with nurses finding they had less autonomy to 
push for allocated research time within their roles:  
“A frontline nurse is going to find it very difficult (I think) to be allocated time, we are 
like every other NHS Trust, stretched to the bare bones at times, especially at this time 
of year, and to say to somebody, oh well, you’re going to be taking two days off a 
month to do this bit of this research project, I don’t know how that would work” – 
Patient governor 
In contrast, higher-band staff, belonging to professions with established research experience, 
had a stronger prerogative to incorporate research activity into their workplans. This disparity 
forces lower-band staff to pursue research using their own time and resources, a prospect 
which can deter enthusiastic but inexperienced researchers. 
“They say ‘oh, it's really good, because you're building the profile of the hospital up’, 
but you don't get protected time for it. So, say I need to spend a day in a conference 
and I have to travel…when I come back I have to catch up with all my work. I take it 
as annual leave that’s how I get round it. But then you know, to use half your annual 






However, even for doctors who are allocated time for ‘Supporting Professional Activities’ 
(SPAs), this rarely equated to protected time specifically for research. Even if a clinician has a 
SPA, these cannot be ringfenced for research as SPAs include other roles such as management 
duties. Additionally, clinicians still have clinical commitments that can dominate their schedules 
and prevent substantive engagement with research. After clinical duties into SPA time, 
clinicians are “lucky if they will allow two hours a month…how can you possibly deliver PI 
oversight in that time?” – R&D Manager  
This situation is further exacerbated by the poor visibility of research support schemes, which 
is primarily rooted in differences in how research and non-research active staff are 
communicated with. As our survey respondents explained:  
“I am research active, so I know where everything is and I actively pursue that, but if 
I wasn’t really that engaged in research, I’d not necessarily know where those things 
are and I think we’re still developing ways to communicate where those resources 
are.” – Nurse 
“Research is talked about within the trust but never Radiographer-led research. I 
would be more than happy and willing to participate in research however I wouldn't 
know where to start and there isn't the culture to support it.” – Radiographer 
Once again, this disparity was prevalent amongst health professions with less-established 
research reputations, such as AHPs. One AHP lead was concerned that “you can move through 
various grades even to the point of a consultant nurse, midwife or AHP, and have done no 
research whatsoever with no research training.” Similarly, we heard that contracts and 
The issue of balancing work-life priorities was echoed in our survey and was rated the 
fourth greatest barrier overall to becoming more research active. This was exacerbated by 




communication were not geared towards research for nurses, meaning “it’s not the culture for 
us to do it…we do it either accidentally because we're trying to do something else, or you 
have an interest in it.” Although research is still going ahead within these professions, our 
stakeholders emphasised just how much effort was required to achieve this. As one clinical 
nurse specialist explained: 
“we struggle and just try and learn on our feet, rather than being coached or guided 
into it…we didn't know what support we had in R&D, because especially for nurses 
it's more like, ‘well that's for doctors’…doctors, now they get priority.” 
Positive solutions to this are happening at the local level which can inform the development of 
wider policies: 
To address these barriers to research and unlock more of the NHS’ research capacity, we need 
to achieve three changes to how time for research is allocated and resourced: 
1. Schemes that provide support for researchers, including allocated time for research, 
must be made more visible, particularly to under-represented professions. 
2. Time for research must be distributed more equitably amongst professions, in order to 
make research more accessible to under-represented professions. 
3. The total supply of time for research allocated to health service staff must increase, 
both to expand NHS research capacity and provide more opportunities to non-research 
active staff. 
The breadth of ‘under-represented professions’ is wide and cannot be exhaustively detailed in 
this report. Instead, nurses, midwives and AHPs have been identified as representative 
examples of these inter-profession disparities. 
One potential solution would be to replace Trust-specific frameworks for allocating time for 
research with a nationwide and uniform application system available and visible to all health 
service staff. This could make research time much more accessible, as a national application 
route could be designed to account for existing inter-profession disparities in research 
engagement and be widely publicised amongst all health service staff. However, a uniform 
Good practice examples:  
✓ Bringing research into departments by offering supervision to PhD students who then 
strengthen the clinical element of their study – offering greater contact with research without 
being away from clinical time. (Betsi Cadwaladr University Health Board) 
✓ Research Champion programmes with diverse uptake and promoted through varied channels 
which emphasise their clinical as well as research interests. (Kent Community Health NHS 
Foundation Trust) 
✓ Local agreement of time for research agreed and supported within teams (Sandwell and West 
Birmingham Hospitals NHS Trust) 
✓ Research time provided through country specific fellowship schemes – NRS in Scotland – 
supported by mentoring and support through a local university research centre (NHS 
Lanarkshire) 
✓ Joint roles between the health organisation and a local university to develop and support 
research within a particular profession (across a number of health boards and universities in 
Scotland; reported by NHS Lothian) 
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system risks ignoring Trust-specific needs and challenges (such as limited research facilities) 
which need to be addressed in order to reduce regional disparities in research engagement. 
Instead of a national approach, we should give individual Trusts/Health Boards the autonomy 
to develop their own strategies for improving the accessibility and visibility of research support 
schemes - including time for research. For example, Trusts/Health Boards could begin offering 
health service staff (across all professions) contracts that includes dedicated time for research, 
as recently suggested by the Academy of Medical Sciences.22 To provide a clear incentive and 
feedback mechanism, Trust performance on making time for research more equitable should 
be monitored and evaluated using research metrics and reviews (theme 4). If a Trust 
successfully makes dedicated research time more accessible then this should be reflected in 




Making time for research more accessible and visible will be a positive step in expanding NHS 
research capacity, but alone, it is not enough. The number of opportunities to access time for 
research is dependent on funding, as this directly finances research projects and backfills roles 
engaged in research. Yet despite its importance, voices at all levels of the health service stated 
that more generous and better-targeted financial support was needed to fund research, 





The NIHR, CSO, HCRW and HSC R&D are pivotal funders of medical research conducted within 
the NHS. They directly fund innovative research and facilitate collaborative research by acting 
as a forum for researchers (e.g. NIHR’s Clinical Research Networks), which in turn develop 
research expertise and capacity within a network that researchers across the NHS can tap into.  
Given their role in expanding the NHS’ research capacity, the NIHR CSO, HCRW and HSC R&D 
are ideal vehicles for increased government R&D spending, especially now given their role in 
facilitating vital COVID-19 clinical trials in NHS Trusts/Health Boards across the country. Not 
1. We therefore recommend NHS Trusts and Health Boards should increase the visibility 
and accessibility of dedicated time for research in order to expand research 
engagement amongst staff, especially under-represented professions. Progress towards 
this goal should be locally monitored using the research metrics and reviews we also 
recommend, as well as periodically reviewed by national NHS bodies. 
2. In-line with the Academy of Medical Sciences' proposals, the UK Government and 
Devolved Administrations should implement fully funded pilot programmes that offer 
a proportion of health service staff (including those in under-represented 
professions) contracts that include dedicated time for research. 





only would uplifting their funding provide an invaluable stimulus to the growth of UK medical 
research, it would also make progress towards achieving the Government’s target of spending 




Our research identified regional, professional and specialty disparities in research activity as an 
urgent and severe challenge to developing the capacity of health service staff to deliver 
research.  
According to data gathered by the NIHR CRN, MRC, and UK Clinical Research Collaboration, the 
UK has been persistently marred by stark regional disparities in research capacity and activity. 
Because research has a positive relationship with patient outcomes,3,20 these regional 
disparities in research activity contribute to regional inequalities in quality of care. In other 
words, there are UK regions where patients are being ‘under-served’ by their Trust/Health 
Board’s lower research activity, compared with more Trusts and Health Boards more engaged 
with research.   
Alongside regional disparities, there are significant professional disparities in opportunities to 
engage in research. Nurses, midwives, AHPs and other under-represented professions report 
having significantly less to access dedicated research time, funding and support when 
compared with professions such as doctors.75,76,77,78,79 However, even within well-represented 
professions, disparities exist. As a recent report from the Royal College of Physicians 
highlighted: physicians who are women, in rural hospitals, or from ethnic minority communities 
have access to fewer opportunities to participate in research.80 
Rectifying these disparities will require additional public investment in research targeted at 
under-served regions, professions and specialties. This investment must be informed by the 
research metrics described in theme 4, and by a review of regional imbalances in research 
activity. Key to this will be local consultation with staff to identify the social and cultural barriers 








Key messages: Theme Two 
 
• The government must resolve the persistent regional disparities in research funding, 
infrastructure and training. 
• There is substantial variation in research engagement between health service staff, 
with doctors and other established research professions receiving greater access to 
research funding and support; this must be addressed. 
• Similarly, disparities in research opportunities between specialties must be 
addressed in order to increase research capacity across the breadth of the health 
service. 
3. We therefore recommend the UK Government and Devolved Administrations should 
uplift long-term funding for the NIHR, CSO, HCRW and HSC R&D. At a minimum, these 
funding increases should be in-line with broader uplifts in public R&D investment and 
keep pace with future increases in inflation. 
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Regional variations (both between and within nations) in research activity remain a persistent 
obstacle to bolstering the UK’s research capacity. A wide array of factors can cause these 
disparities, meaning they vary in severity and scope. For example, some community and non-
teaching Trusts/Health Boards are forced to deprioritise research due to limited capacity, 
especially those that lack an affiliated medical school, as this makes it harder to attract and 
retain staff with research training and experience. For example: 
“In Scotland, research is a key element in four main Health Boards associated with 
university medical schools – Edinburgh, Glasgow, Aberdeen, Dundee, but other 
smaller Boards have much less research activity” – Research & Development Director 
Regional variations also have significant impacts on access to research opportunities for health 
service staff.  As one Deputy Head of Dietetics Services suggested: 
“In a bigger hospital you’ll have a whole team of head and neck dietitians, and they 
all work so much better and they’ve got the opportunity to do so much more research. 
It is frustrating from that point of view because, I think the will is there but it’s just 
the practicality, don’t allow you to do it (in smaller trusts).”  
There was a consensus amongst our interviewees that the allocation of funding is skewed 
towards larger Trusts/Health Boards with established research capacity and expertise. By 
prioritising established expertise, rather than potential, research investment reinforces 
regional disparities and concentrates the development of research staff and facilities into these 
larger Trusts/Health Boards. Our survey data reflect these trends, showing how staff from less 
research-active Trusts/Health Boards (as defined in Figure 6 below and Appendix Table 1.1) are 
more likely to experience barriers to research such as lack of confidence in research knowledge 
and skills, limited research culture in their department/organisation, no protected time for 




Figure 6: Barriers to research activity in less research-active versus more research-active 
Trusts/Health Boards 
 
Note: NIHR Clinical Research Network research activity quintile data is used to divide more research active 
Trusts/Health Boards (quintile 1-2, top 40%) and less research-active Trusts/Health Boards (quintile 3-5) in our 
sample. 
 
Targeted funding for non-teaching or less research-active Trusts/Health Boards, driven by a 
long-term vision for addressing regional disparities, was widely recommended by interviewees 
as an essential step in building research capacity. This targeted funding will enable less 
research-active Trusts/Health Boards to develop the research experience of their staff and 
expand their research facilities, both key factors when competing for funding. Achieving this 
will require research funders, authorities and NHS organisations to work collaboratively in 







Alongside direct research investment, access to research training was identified by 
interviewees as an essential (but often absent) driver of increasing research capacity in less 
research-active Trusts/Health Boards. We heard through our interviews that support sessions 
provided by external research networks to Trusts/Health Boards (e.g. free research training 
from Higher Education Institutions) were invaluable for health service staff working to develop 
their research capacity. These sessions laid the groundwork between health service staff and 
academic staff to develop partnerships between less-research active Trusts/Health Boards and 
4. We recommend the UK Government should conduct a regional review of clinical 
research activity. The review's findings should inform proposals for additional funding 
that facilitates increased research engagement within regions currently under-served 
by research. The review's findings should also inform revisions to existing R&D 
investment, with a view to making this investment more regionally equitable and 






HEIs and research-experienced Trusts/Health Boards. Such partnerships could further develop 
research capacity by providing health service staff with a network of experienced researchers 
who can advise less research-active Trusts/Health Boards, on issues ranging from applying for 
funding and setting research strategies to developing study methodologies and engaging with 
research regulators. These partnerships should be a central feature of the integrated research 
offices and academic-clinical setting exchanges described in theme 4. 
 
Another key factor emerging from our scoping review and empirical studies was the clear 
disparity of research engagement between different health service staff, with nurses and AHPs 
being particularly under-supported and under-represented in research activity undertaken by 
Trusts/Health Boards.81 To ensure our survey and interview data represented the full breadth 
of health professionals, we consulted health service staff working across a wide array of roles, 
including those who are, and are not, engaged in research. 
Our interviews explained that the competitive nature of some research programmes meant 
they favoured experienced principal investigators and doctors over inexperienced staff with 
research potential. This disparity was less apparent in research programmes specifically 
tailored to engage professions that are under-represented in research, such as nurses and 
AHPs. These tailored programmes are necessary because many health professions have less 
access to support mechanisms such as: allocated research time; funding opportunities; 
research networks; resource allocation; and learning programmes.  
“There is a lot of barriers because you are nurses, and as nurses you are viewed as 
why are you doing research? Why do you want to do this? It's not in your job 
description, you are not in an academic job role, so all the priority goes to the doctors 
that are in academic job roles or the new assistant roles that are coming out, that’s 
more academic assistance. So, all the resources from a nursing point of view goes to 
them.” – Nurse 
This disparity is reflected in our survey data, which shows different responses to the barriers to 
research activity questions between the job role groupings (Figure 7).  
Good practice examples:  
✓ Linking academics and external experts to Trusts/Health Boards to work alongside 
health service staff, e.g. Kent Community Health NHS Foundation Trust collaborates 
with a newly established medical school, universities, national experts and 
international research teams.  
✓ Building partnerships between research-active and smaller trusts e.g. Guy's and St 
Thomas' NHS Foundation Trust working with Darent Valley District General Hospital 
(Dartford & Gravesham NHS Trust) 
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Figure 7: The research active pathway 
 
Our interview and survey data show that even when nurses and AHPs overcome these barriers 
and successfully participate in research, their value and contribution is recognised and 
encouraged less than doctors. A few interviewees noted frustration that although a high 
proportion of research clinics and daily work are nurse-led, the nurses usually only get a 
mention in the appendix in publications of the resulting studies, with authorship almost always 
given to the Principal Investigators (typically doctors). These interviewees suggested that 
authorship should be more representatively presented to ensure that the contributions of all 
staff are acknowledged. This lack of visibility in research output contributed to a feeling 
amongst some nurses, midwives and AHPs that they were a lower priority for research funding 
and investment. Interviewees criticised the limited information given on available funding 
opportunities, with doctors and other experienced researchers receiving more active support 
from R&D boards when pursuing funding.  
“Depending on whether you are a clinician or AHP or Nurse or any other professional, 
the funding is disproportionately skewed to doctors rather than anyone lower on the 
food chain.” – AHP Lead 
Many schemes have already been established to level the playing field across health 
professions and reduce these disparities: 
 
Good practice examples: 
✓ The 70@70 NIHR Senior Nurse and Midwife Research Leader Programme as an 
initiative specifically aimed at nurses and midwives raising research awareness, 
understanding, capacity and capability. 
✓ Health Education England’s Integrated Clinical Academic Programmes (ICAPs) provide 
key early-career opportunities to develop research capacity. One case study involved a 
physiotherapist using the programme to backfill some clinical time to develop research 
proposals and apply for the NIHR’s Clinical Research Doctoral Fellowship. 
✓ NIHR’s Research for Patient Benefit Programme fund research that will directly 
improve patient care, drawing from the clinical experience of under-represented 




Further support targeted at under-represented professions is required to bolster their 
participation in research and expand research capacity. This support needs to be highly visible 
and accessible to these professions and include solutions to the practical obstacles to research 
engagement, such as a lack of time and funding. An awareness of the competition for funding 
and how this can discourage under-represented professions is also needed to ensure all staff 






Alongside increasing the participation of under-represented professions, many interviewees 
and survey respondents called for greater diversity of professions within research project 
teams, especially in positions of leadership. Greater access to these positions would enable 
under-represented professions to lead on the development of research questions and outputs, 
ensuring both address practical issues drawn from their clinical experience. 
 
Increasing the funding and research opportunities available to these professions will certainly 
be necessary to achieving this goal. However, Trusts/Health Boards must also consult under-
represented professions and identify the social and cultural barriers to their engagement with 
research (including the impact of racism and sexism). This consultation must then inform 
concrete strategies designed to address these barriers, progress towards which should be 






Finally, our research also identified disparities between specialties. This adds another axis of 
inequity, with prevention, public health, pharmacy, and mental health being some of research 
fields that experience underinvestment. The lack of support makes it harder for researchers in 
Good practice examples: 
✓ Build a broad mix research interest group and maintain communications, involving 
health service staff who are not doctors (Kent Community Health NHS Foundation 
Trust) 
✓ Take a move to be research active and promote clinical academic careers with nurses 
and allied health professionals (Guy's and St Thomas' NHS Foundation Trust) 
✓ Through delivering the in-house nurse training academy, the trust has greater potential 
to integrate research as well as into clinical practice (Kent Community Health NHS 
Foundation Trust) 
5. We recommended national and local research funders should increase the funding that 
is targeted towards under-represented professions. This should include increasing the 
number of structured opportunities for these professions to participate in research (e.g. 
Clinical Studies Groups and NIHR Specialty Clusters focusing more on involving under-
represented professions).  
 
 
6. We recommend local NHS R&D Offices and Human Resources departments should 
collaboratively consult under-represented professions to identify and address the 
social and cultural barriers they face to engaging with research. Progress towards this 
goal should be locally monitored using the research metrics and reviews we also 




these areas to recruit patients, develop research experience, and evidence the value of their 
research. This reflects the broader pattern of investment favouring established expertise over 
potential, which in turn limits cumulative research activity and capacity-building across the 
entire health service.  
Interviewees agreed that access to funding and research support needs to be equally 
distributed across specialties in order to reduce this disparity. Achieving this will require better 
monitoring of this resource distribution and research activity within specialties, which can be 
achieved through the research metrics and review we propose (theme 4). This is necessary 
because each specialty faces its own unique set of barriers to expanding research capacity and 
therefore requires tailored solutions that will be informed by this improved monitoring.  
Clinical Studies Groups (CSGs) would be an optimal vehicle for delivering tailored funding, 
training and support schemes. CSGs are multidisciplinary networks of researchers that work 
with a range of stakeholders to identify research priorities and secure research funding. By 
acting as ‘hubs’ for their specialty, CSGs provide an invaluable platform designing and 
implementing schemes tailored for under-supported specialties. Alongside CSGs, the NIHR’s 
Specialty Clusters (though broader in scope) would also be invaluable in delivering change, 
especially thanks to their relationship with a key life sciences research funder. Devolved 
equivalents of NIHR Specialty Clusters should also be utilised where available. 
 
 
Alongside profession- and specialty-specific barriers to developing research capacity, our 
interviewees and survey respondents noted that all health service staff can experience barriers 
on the pathway towards building a research career. Figure 8 identifies critical points along the 
research career pathway and various factors that enable or frustrate research development. 
Our findings demonstrate the importance of looking beyond providing one-off opportunities. 
Instead, resources and support for research engagement must be continuously applied along 
the career pathway, cumulatively developing research experience, skills and capacity. 
Interviewees and survey respondents raised the lack of sustainability behind career 
development support, particularly during and beyond early entry into research: 
“When I finished my PhD fellowship and was going to come back to my NHS post, 
there was no job for me. So I ended up jobless for almost four months before I got 
back into an NHS post, and in there they didn’t recognise my increments, because I 
was in an academic post, although I was working all that time in the NHS. I actually 
took a pay cut to go back to my job.” – Nurse 
There is also an urgent need to increase access to research training across all healthcare 
professions in order to fill the confidence gap many prospective researchers have about their 
skills and expertise. Finally, we must ensure NHS research does not become a one-size-fits-all 
system and instead develop multiple research career pathways in order to reflect the diversity 
of research motivations and professions. 
 
7. We recommend the UK Government and Devolved Administrations should invest more 
in under-served specialties and engage with their networks (e.g. CSGs) to identify 















Key messages: theme three 
 
• Resources and support for research engagement should to be applied along the 
career pathway in a cumulative way instead of one-off opportunities. 
• Insufficient research training and lack of research knowledge and skills is one of the 
top barriers for health service staff to be involved in research activities. It is 
important to invest in a life course approach to research to facilitate early and 
continued exposure to research.  
• There should not be a ‘one size fits all system’, instead, it is important to be inclusive 
and acknowledge the diversity of pathways into and through research. 
• Research should be embedded across organisational-level decision-making, 
including in workforce planning. 
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Early exposure to research provides an invaluable opportunity for health service staff seeking 
to build research confidence and skills. Our interviewees stressed the importance of involving 
students in practical research studies and providing them with research training before 
entering clinical jobs, regardless of whether research is a core function of that job: 
“Having that opportunity while they’re a student gives them a chance to understand 
better what the role is and what’s involved in it, even if they don’t end up as research 
nurses then, you know, at least they have developed an understanding of it hopefully” 
– Nurse 
Yet despite the value of early exposure, some interviewees suggested that they had research 
as a mandatory part of the curriculum at medical schools, yet “with several lectures discussing 
‘research’, I have not been trained to actually carry out a research project”. Our survey data 
also showed that “research needs de-mystifying for people”, with insufficient research training 
and lack of research knowledge being one of the top barriers inhibiting staff’s involvement in 






Overcoming this challenge will require a substantial increase in the number of opportunities 
made available to early-career researchers to develop confidence, experience and skills. 
Numerous existing schemes (see above) are already pursuing this goal, though each face 
obstacles that inhibit their success. A notable obstacle identified by our research is the 
opportunity cost associated with research, a cultural attitude that sees research as an add-on 
to clinical work, not an integral part of it. Reducing this perceived opportunity cost is essential 
to successfully implementing research funding and support.  
Many interviewees emphasised the importance and necessity for Trusts/Health Boards to 
support health service staff to deliver small-scale research projects that build expertise and 
experience. Pathway to Portfolio not only delivers skill-oriented projects but does so in a way 
that minimises the perceived opportunity cost of research. Firstly, Pathway to Portfolio projects 
can only last 6 months, thereby limiting the time cost faced by applicants wary of longer 
Good practice examples: 
✓ Pathway to Portfolio Development Funding Scheme open to all healthcare staff in 
Wales to fund small-scale research scoping projects that will develop research skills 
such as grant-writing, research question design, and community engagement. 
✓ Clinical Research Time Award open to staff in NHS Wales, or staff contracted to NHS 
Wales, such as doctors, dentists, nurses, midwives, allied health professionals and 
clinical scientists. 
✓ HEE Integrated Clinical Academic Programme provides research training awards for 
health service staff (excluding doctors and dentists) to develop careers that combine 




85% of survey respondents agreed that research training would support health service staff 




schemes. Secondly, projects receive a maximum of £20,000 in funding, thereby forcing 
applicants to limit the scope to small (but achievable) objectives that directly develop research 
skills (e.g. research question design). The effectiveness of this approach is reflected in the 
scheme’s established track record of success as well as its alignment with other key objectives, 





In addition to early research exposure, health service staff need sustained exposure and active 
support to aid in the development of research skills and experience. For example, in Betsi 
Cadwaladr University Health Board, collaboration with universities has enabled health service 
staff to supervise PhD students.  
 
Whilst the exact shape of this continued research exposure will vary between organisations 
(due to differences in funding, staffing and facilities), a focus on mentorship and role models 
should be core to Trust/Health Board programmes. The value of role models, both to inspire 
new researchers and ‘bang the drum’ for research in Trusts/Health Boards, was repeatedly 
emphasised by interviewees and survey respondents. Mentorship is also an opportunity that 
can be afforded by greater collaboration and knowledge sharing between clinical and academic 






Alongside increasing the number of opportunities for health service staff to engage with 
research, we must also increase the visibility and accessibility of opportunities in order to 
prevent NHS research from becoming a one-size-fits-all system. This is necessary because staff 
have a diverse array of motivations for engaging research, each of which demands different 
types of support: 
Good practice examples 
✓ Embed structured opportunities for secondments to work as research nurses to 
promote the cross over between clinical and research roles. (Guy's and St Thomas' NHS 
Foundation Trust & South Eastern Health and Social Care Trust) 
✓ Learn from those professions (e.g. doctors) which already have clearer pathways in 
place and pilots where research has been added into the job plan (Betsi Cadwaladr 
University Health Board). 
8. We therefore recommend the NIHR, CSO and HSC R&D should develop new 
programmes modelled on the HCRW's Pathway to Portfolio Development Funding 
Scheme to fund small-scale projects that develop the confidence, expertise and 
capacity of NHS staff to deliver research. 
 
9. We therefore recommend local NHS R&D Offices, with support from their NHS 
organisations, should establish mentorship programmes that pair prospective 
researchers with established researchers. These programmes should be available to 
all health service staff and be designed to support staff's professional development 






Figure 9: Top 5 factors that motivate health service staff to be research active 
 
Personal interest in a research topic, for example, is a more effective motivator for research 
engagement amongst non-research active staff compared with established researchers (Figure 
9). In contrast, established researchers are more actively motivated by a desire to develop their 
department’s profile and their own personal learning compared with non-research active staff; 





Ensuring all health service staff are aware of research’s place in their Trust/Health Board should 
help raise the visibility of opportunities to engage with research and establish a clear, 
organisation-wide motivation to do so. Including all staff will also aid efforts to make research 
participation more accessible to under-represented professions, who may not currently be 
aware of their organisation’s research strategy and their potential role within it.  
 
Efforts to bolster the visibility and attractiveness of research engagement can be further 
enhanced by amending Trusts/Health Boards’ workforce strategies. Engagement with research 
can improve job satisfaction and staff retention rates, especially when that research clearly 
translates into improved patient care. Trusts/Health Boards should more actively utilise this 
principle to bolster the effectiveness of their hiring, retention and development strategies.  
Good practice examples 
✓ Including research, audit, and quality of care improvement in job descriptions and 
work plans to raise research’s profile amongst staff, including middle managers (NHS 
Lanarkshire). 
10. We recommend the onboarding  process for all NHS staff should include an induction 
on their Trust/Health Board's research strategy, how it is being operationalised (e.g. 
research time applications, funding opportunities, secondments, etc.), and the role 





For example, many interviewees suggested having research as part of promotion criteria. This 
could be achieved by emphasising patient benefit and outcomes rather than publications in 
high impact journals alone and could support progression. Similarly, respondents highlighted 
the need to move away from a “training and then get on with research” model, and instead 
shift towards a lifelong career development approach. These career pathways were suggested 
to include a wider scope on how to develop their roles and grant autonomy to be able to take 
patient care and research further, which “allow us the ability to be able to do that and to have 
our skills recognised better”.  
 
How research should be embedded into these strategies should be a decision made locally by 
Trusts/Health Boards, as they are best positioned to understand their own staffing needs. 
However, we do recommend these new strategies be informed and monitored using the 
metrics and reviews we propose in theme four. This could include linking this policy with wider 
NHS workforce policies, such as the NHS People Plan. 
 
Taking the steps above will provide an essential foundation for greater NHS research capacity. 
However, our interviewees and survey respondents repeatedly stressed the necessity of strong 
Trust/Health Board-level research cultures. Our research identified it as a pivotal driving force 
behind research engagement and efforts to develop research capacity. 
We define a strong research culture as a joined-up environment where research is valued, 
normalised and supported through by both strategic decision-makers and operational health 
service staff. This requires all stakeholders (including patients and the public) to understand 
and see research’s beneficial impact on patient care. 
Although our interviews and survey identified positive initiatives being taken to strengthen 
research culture, we found there are often significant gaps between ambitious national 
strategies and local practice. This gap is exacerbated by the lack of national- or local-level 
evaluation of where research occurs and why. The result of these gaps is a ‘siloed’ culture of 
research where research-active Trusts/Health Boards work within themselves and other 
research-experienced organisations (e.g. universities), depriving themselves of day-to-day 
clinical insights gathered by organisations under-served by research.  
Addressing this requires improved monitoring of research activity on both a national and local 
scale. The patient benefits of research must also be visibly and routinely communicated by local 
leaders in order to build greater staff interest in, and understanding of, research’s role in 




11. We recommend that NHS Trusts and Health Boards should embed research into their 
strategies for staff recruitment and retention, and workforce development planning. 
These local efforts should be reinforced by ambitious national strategies for supporting 


















At the national, or macro, level there was widespread support for strategies to raise the profile 
of research, such as the Life Sciences Industrial Strategy. However, our national and local 
stakeholders felt that these national strategies were not sufficiently joined up or rooted in local 
practice to be effective. Similarly, at the meso or health organisation level, there was concerted 
effort to increase research activity. Yet, gaps remain between strategic statements about 
research and their delivery in practice, even among those Trusts/Health Boards with an explicit 
research strategy in place. Support for research activity at the micro line management level 
was therefore inconsistent, despite several committed and supportive managers and team 
leaders.  
Throughout our interviews, we heard that these inconsistencies make it hard to embed and 
integrate aspects of a strong research culture, such as policies which value research, make 
engagement feasible and recognise research activity and achievements in job planning.82,83 This 
was illustrated through our survey where respondents were more likely to agree with general 
‘mission’ statements than they were with statements about the organisation delivering 






At both board and middle management levels, there is a need to provide structured and 
meaningful insight into the value of research. We asked our survey participants about the role 
of research within their Trust/Health Board’s clinical strategy (i.e. setting the direction across 
services and disease areas), and broader organisational strategy (i.e. how to realise the clinical 
strategy, such as workforce). Amongst 45 surveyed senior managers (medical directors, chief 
Key messages: theme four 
 
• There are multiple gaps between positive research strategies and their delivery in 
practice at the local level. This makes it hard to achieve a more consistent and 
embedded research culture. 
• There are insufficient metrics and processes to capture, report and communicate 
research value in its diverse forms – this makes it difficult to evidence its importance 
at the board, middle management and staff levels.  
• Stakeholders acknowledged that moving beyond ‘silo cultures’ through partnership 
between Trusts/Health Boards and academia was the key to extending research 
understanding, debunking research myths and strengthening infrastructure. 
• Healthcare organisations must better communicate research’s role in improving 
patient care in order to engage non-research active health service staff. 
73% of survey participants agreed with the statement, ‘my organisation sees research and 
evaluation as integral to our work’, whereas only 51% agreed with the statement, ‘my 




nurses and AHP leads), 44% were unsure about whether research development was a main 
priority within their Trust/Health Board’s clinical strategy or overall organisational strategy 
(Figure 10).  
Figure 10: The role of research in strategy  
 
Illustrating the importance of research to staff is not clear cut, however. Respondents across 
professions and specialties described a ‘chicken and egg’ scenario: even where high quality 
research is delivered, evidence of research value was not systematically collected or routinely 
reported at leadership level. This was exacerbated by a relatively low number of research-
experienced, or high profile, role models to ‘bang the drum’ for research and normalise 
research activity. As a result, it was difficult to keep research on the agenda, potentially 
weakening its profile.  
One AHP echoed the feeling of many health service staff in describing research as a “nice to 
have” rather than an integral feature of their health organisation. This separation was further 
illustrated by a Pharmacist who felt research was seen as something delivered or used by 
specialists. They noted research active staff were “put on a sort of a pedestal of ‘you’re a 
researcher so you understand this and I’m not so I don’t get involved.” This both fed into and 
resulted from research not being seen as essential to improving patient care and clinical 
outcomes. Our interviewees felt that this effectively deprioritised not just involvement in 
research but also the use of research results, with health service staff not having the time to 
utilise others’ academic research and evidence.  
In response, our interviewees and survey respondents repeatedly recommended developing 
new research metrics, explaining that improved monitoring of research’s value could reverse 
its deprioritisation by decisionmakers. Efforts to implement this have been made, with the CQC 
introducing new research-oriented questions into its well-led framework for evaluating patient 
care.84 
However, there was a caution to ensure these measures were appropriate and stimulated a 
positive research environment. To more consistently contribute to a stronger research profile, 
they stressed the need to illustrate the diverse and meaningful ways that research can add 
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value ensuring, as one service lead suggested, “we make sure we measure the things that 
matter to the service, not the things that are easy to measure.” Among the items our 
respondents suggested to illustrate the breadth of research impact were: 
• impact and value in terms of patient experience, outcomes and perceptions; 
• staff morale, retention, connectivity and development; 
• systems improvements; and 
• potential cost savings. 
 
A version of this proposal has been previously recommended by the Academy of Medical 
Sciences.85 We seek to build on it by couching it into a package of policy responses designed to 
use the metrics to aid their implementation.  
Alongside this, it is essential that local R&D Offices consult their staff and patients to 
understand local challenges and opportunities to research engagement. Examples of this local 
monitoring already exist and should be learned from. For example, staff at the Betsi Cadwaladr 
University Health Board have organised to hold the Board’s research strategy to account, 
highlighting the need for a rigorous and joined-up approach to research. Similarly, NHS Lothian 
has used its annual activity reviews of funded researchers to quantify and assess the quality of 
their contribution using locally developed metrics, which in turn better illustrated and 
communicated research’s value to decision-makers. 
These local reviews should be designed to provide qualitative insights into staff and patient 
engagement with research – this should sit separately to the more targeted consultations with 
under-represented professions (theme two). These insights should then be used by 
Trusts/Health Boards to inform the design and implementation of their research strategies in 





Both initiatives are required to address the gaps between ambitious national research 
strategies and local practice. The quantitative metrics will provide national decision-makers 
with a clearer picture of where research takes place, enabling them to quickly identify failings 
in existing strategies and provide targeted support. Simultaneously, the qualitative reviews will 
provide local decisionmakers with a more tactile understanding of their organisation’s specific 
barriers to research activity, which can then inform Trust/Health Board-level strategies and 
decisions.  
12. We recommend that all four national departments of health should develop a 
coordinated set of metrics to capture NHS research engagement and impact. These 
quantitative metrics should capture research's impact on patients, staff, NHS systems 
and cost savings. The resulting data should be incorporated into existing platforms for 
evaluating NHS Trusts and Health Boards. 
 
 
13. We therefore recommend local NHS R&D Offices should undertake periodic reviews of 
research awareness and activity amongst their health service staff and patients. The 
resulting qualitative insights should inform local efforts to showcase research's value 





A strong research culture should enable staff to collaboratively explore new perspectives and 
gain insight, support each other’s research, and access a diverse network of insight and 
infrastructure. Our stakeholders acknowledged that achieving this is difficult due to the “silo 
cultures” often associated with large institutions, such as the NHS. The resultant boundaries 
can deter collaboration within and between these organisations, preventing individuals from 
accessing new perspectives and established expertise. The need to overcome these boundaries 






Fortunately, there are already numerous examples of successful collaboration between the 
NHS and other research institutions. In North Wales, Betsi Cadwaladr University Health Board 
and the University of Bangor have piloted a virtual, multidisciplinary Community of Scholars 
network. This platform aims to develop the applied health research infrastructure in North 
Wales by supporting greater collaboration. As well as providing an effective, everyday 
communication and support platform to health service staff spread across a considerable 
geographical area, the network’s remote collaborations and academic relations are even more 
valuable in the context of COVID-19.  
 
This recommendation was originally made by the Academy of Medical Sciences22 but has yet 
to be implemented. These integrated research offices will play an essential role in developing 
relationships between clinical and academic researchers. This collaboration should improve the 
connection between clinical challenges and research design, spurring innovative research 
projects and providing Trusts/Health Boards with an opportunity to bolster their research 
profile. Academic partners could also help Trusts/Health Boards apply for research grants, 
structure more roles around research, and use research engagement to improve staff retention 
rates. 
However, working with a range of partners at the inter-profession and inter-specialty level is 
not straightforward. Our stakeholders expressed concern over the hierarchy which exists 




14. We therefore recommend local NHS R&D Offices and universities should establish 
integrated research offices in order to facilitate the exchange of research expertise 
and build research capacity. These integrated research offices should be responsible for 
the local implementation of our recommendations (below) to increase formal 
opportunities for inter-profession learning. 
 
 
82% of survey respondents agreed that close ties with local academic organisations or 
industry would support health service staff to be more research active, and 79% thought 
that external research partners would help.  
 
As described in theme 2, nurses, midwives and AHPs had less confidence in their research 
knowledge and skills than doctors, and cited this as a deterrent against engaging in 




For example, some clinical nursing staff felt removed from research and were left with the 
impression that it was the sole reserve of research nurses. This disparity was further 
exacerbated by the two professions being based in different locations, minimising interaction 
and learning between the two. As one research nurse explained:  
“I think that there’s this perception that…research nurses are just sitting in a little 
ivory tower looking at journal articles all day - we’re actually clinical and we’re out on 
the floor and we’re looking after patients…so it’s raising that awareness.”  
Our research identified several initiatives to address this gap and promote inter-profession 
learning. The South Eastern Health and Social Care Trust, for example, has collaborated with 
universities to deliver placements for nursing students within research nurse teams. This 
enabled the students to learn more about research in clinical practice and the opportunities 
available to participate in research. Intra-organisational partnerships have also been 
strengthened at Sandwell and West Birmingham Hospitals NHS Trust where secondments 
between clinical and research nursing teams are providing clinical staff opportunities to engage 
with research and develop their skills.  Similarly, negotiated secondments between Kent 
Community Health NHS Foundation Trust and local universities have enabled clinical staff 
(including AHPs and nurses) to become involved in research for a set number of days per week, 
making it more ‘operationally viable’ for their teams. 
 
To raise and maintain the profile of research, our respondents prioritised studies which address 
real issues faced ‘on the ground’ and are designed to translate well into practice. This sub-
theme considers the barriers and enablers to devising, delivering and communicating this kind 
of research, including: health service staff capacity; confidence and training; data 





Yet despite this strong motivation, interviewees repeatedly stated that they lacked the time 
needed to frame and communicate research questions informed by their day-to-day clinical 
experiences: 
“There’s only so many hours in the day, and when you’re being pulled in every 
direction, something that requires you to sit down and think about how you’re going 
to tackle it goes to the bottom of the pile” – Pharmacist 
This is exacerbated when staff feel unconfident in their research skills and cannot access 
mentors who could build their confidence and guide them through the research design process. 
This lack of support is replicated on an organisational level, with non-research active 
Trusts/Health Boards having a weaker culture of working with staff to generate and evaluate 
15. We therefore recommend NHS Trusts and Health Boards and local universities should 
increase the number of formal opportunities available to their staff to work in 
academic/clinical settings. These secondments should formally focus on building 




90% of research active staff and 87% of non-research active staff consider ‘improving 









Our interviewees said this disconnect begins at the under- and post-graduate level, as there is 
a tendency for student research projects to fit within academic norms and that this does not 
necessarily prepare health service staff to plan and deliver research within clinical settings. To 
address this, many interviewees recommended increasing the number of opportunities 
available to students to undertake research projects connected to clinical practice, thereby 
showcasing how research can be applied practically. We also heard of growing opportunities 
for research-experienced clinicians to co-supervise PhD students at nearby universities, further 
demonstrating the role research can play in driving clinical improvements.  
 
Alongside introducing incoming health service staff to the exchange between research and 
clinical practice, our interviews showed an urgent need to better showcase the value of 
research to existing staff. However, achieving this can be extremely challenging for certain 
specialties. For example, our respondents noted that it was harder to evidence and 
communicate research outcomes for public health studies, especially within short timeframes. 
As one public health service lead noted, “it’s data rich but it’s really difficult to show the 
outcomes of that data because anything you’re doing is years down the line.” This makes it 
harder to showcase the value of these studies to R&D boards and staff, in turn contributing to 
the research disparities between specialties discussed in theme 2. Research that is poorly 
communicated is also less likely to be incorporated into clinical practice and benefit patient 
care, a key motivator for staff to conduct research. This reduces the incentive for staff to 
conduct research since “nobody wants to invest time and effort for the paper or findings to 
sit in a cupboard”. 
In response, our respondents gave a clear message on how to better communicate research 
impact: frame the research as important (rather than ‘interesting’) and showcase a clear local 
application of its findings. Some Trusts/Health Boards are already embracing this approach, 
with Sandwell and West Birmingham Hospitals NHS Trust actively using their Communication 
and Engagement teams, backed by clear managerial support, to effectively disseminate 
research findings and promote their clinical utility. Similarly, Betsi Cadwaladr University Health 
Board has introduced dedicated ‘research days’ where the findings of local research projects 
are presented, and their clinical ramifications discussed by staff. Given the success of these 
initiatives and the clear need to improve the visibility of research, it is strongly advisable that 
all Trusts/Health Boards adopt their own strategies to better communicate the value of 
research to staff, especially those in under-represented professions, groups and specialties. 
16. We therefore recommend that universities should increase the number of 
opportunities for students (across all health service professions) to undertake 
research projects in clinical settings. These projects should formally focus on developing 




Just under 40% of our survey respondents said that their organisation involved health 
































17. We therefore recommend local NHS R&D Offices should frequently showcase and 
promote their research using events, reading groups, consultations and other active 
methods of engagement in order to raise awareness and encourage wider participation 






One of the advantages of investigating this policy area is the wealth of past work done to 
understand and overcome the barriers to research, motivated by a desire to improve patient 
outcomes and develop the NHS’s workforce.3,22,23,86 The need to expand research capacity is 
also widely, and rightly, acknowledged by policymakers as a key priority, leading to ambitious 
strategies like the LSIS and UK R&D Roadmap.  
Yet this sustained policy interest, though undoubtedly welcome, raises a challenging question: 
why do barriers to expanding NHS research engagement and capacity persist? 
In answering this, we encountered many of the same issues identified in previous studies: 
inadequate research support; disparities in opportunity; restrictive career pathways; weak 
research culture; and so on. Many of our findings reflect those found in the Academy of Medical 
Sciences’ report Transforming health through innovation: Integrating the NHS and academia.87 
The AMS’ report offers invaluable insight into the challenges NHS researchers face and we 
sought to build on four key areas of the report’s recommendations:  
• Taking a system-wide approach to supporting and valuing research. 
• Integrating research teams across academia and the NHS and establishing joint research 
and development offices. 
• Providing dedicated research time for staff to become research-active across all 
professional groups. 
• Improving career pathways for research from the undergraduate curricula through to 
postgraduate training pathways. 
We built on their study by adopting a system-based approached centred on Gee and Cooke’s 
framework of developing research capacity.43 We found that existing capacity-building 
initiatives fail for many reasons, including: competing objectives and priorities; lack of 
resources; dispersed actors responsible for implementation; lack of accountability; and poor 
communication.8890 To avoid these pitfalls, greater emphasis must be placed on the 
interconnected nature of these problems and the need for an integrated package of policy 
solutions.  
To provide clearer strategic direction and to increase the incentive for local leadership to 
prioritise research, NHS research must be given equivalent status with other national targets 
for NHS Trusts/Health Boards. This will ensure it is taken it seriously as an objective. This 
strategy must be co-developed by national policy makers -including those responsible for 
workforce and education/training - research funders, and regulatory bodies. Inclusion in 
regulatory reviews (e.g. CQC well-led framework) is welcome, but local implementation will be 
dependent on a clear, cohesive national framework supported by all stakeholders and proper 
analysis of key barriers to increasing staff research capacity at a local level.    
Positive action should be taken to address disparities in activity and funding between 
professions, regions, specialties and demographic groups. Approaches such as linking research 
active and non-active Trusts/Health Boards and monitoring how resources are allocated across 
the system are promising strategies, but require sustained support at a national level to be 
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impactful.88 Research funders should address disparities in funding by giving greater 
consideration to the accessibility of funding schemes and addressing unnecessary barriers to 
new researchers. Doing so would also help accomplish a key NIHR objective of improving the 
link between research activity and local population needs.  
Awareness of research and opportunities to develop research skills should be available to all 
staff, from pre-qualification training and throughout an individual’s career. Research should 
have equivalent status to practice, as applying evidence to practice is an important professional 
competence. Opportunities should be made available to support diverse ways for staff to gain 
exposure and experience along clearly communicated, incremental pathways.  
Research must be embedded in organisational culture and be part of healthcare workforce 
plans and organisational development plans. To be successful this needs to be supported by 
changes to infrastructure support, education and training, funding opportunities and 
organisational strategies for recruitment, staff development and time allocation of staff. 
There needs to be greater local collaboration between research active and non-research active 
organisations: where NHS Trusts/Health Boards with lower levels of research activity were 
linked together with successful research-active ones, there was a clear transfer of knowledge 
and skills and improvements in research performance. Similarly, linking academic researchers 
with NHS staff improved research capacity. Developing infrastructure to support links such as 
joint research offices appears to be an effective intervention.  
This interconnected response (Figure 11) must be overseen by a body with a clearly established 
mandate for monitoring the implementation of each individual policy by its respective body 
(e.g. NHS Trusts/Health Boards). We recommend DHSC and the Devolved Administrations 
should be given responsibility for ensuring this report's recommendations are implemented as 
an integrated package of policy solutions to the systemic challenges afflicting NHS research:  
• Filling the gap between national strategy and local practice – Research needs to be 
embedded in local organisational culture, with metrics and consultations in place to 
capture research awareness and inform wider strategies.  
• Demonstrating research’s patient benefits – Improvements to care driven by research 
need to be better communicated to staff and patients, preferably in tandem with 
established researchers in other organisations and local universities. 
• Resolving disparities in research engagement – Regional imbalances must be 
addressed in order to improve the link between research activity and local population 
needs. We must also more equitably distribute research opportunities amongst both 
healthcare professions and specialties, working with under-represented staff to identify 
and solve whatever barriers they may face. 
• Establishing accessible research career pathways – All staff should be aware of 
opportunities to develop research skills and be onboarded into their local research 
strategy. Organisations should adopt research as a central pillar of their workforce 
planning and follow this through with programmes such as Pathway to Portfolio. 
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• Providing the time and resources needed to succeed – All prospective NHS researchers 
should have the opportunity to apply for, and access, dedicated time for research. NHS 
Trusts/Health Boards also need adequate funding to develop and maintain their 
organisation’s research capacity, including currently research-inactive Trusts/Health 
Boards. 
Figure 11: The interconnected policy response  
Looking forward, it is essential that stakeholders across the life sciences sector voice their own 
ambitions for the future of NHS research, the immense value of which has been repeatedly 
demonstrated through the course of the COVID-19 pandemic. With that in mind, we encourage 
the Government to use its Comprehensive Spending Review and recently announced UK R&D 
Roadmap to take ambitious forward in achieving the above goals. 
Following this report, we will continue to critically evaluate the challenges faced by health 
service staff researchers and maintain our commitment to making research accessible to all. 
This includes CRUK’s responsibility to confront systemic racism and racial prejudice in scientific 
research,91 an issue which we aim to examine in greater in detail in future policy reports as part 






Throughout this report, we have put forward a number of recommendations across four key 
themes, which together will form an interconnected policy response to overcome persisting 
barriers to research and build research capacity in the NHS.  
 
We recommend DHSC and the Devolved Administrations should be given responsibility for 
ensuring this report's recommendations are implemented as an integrated package of policy 
solutions to the systemic challenges afflicting NHS research.  
 
While all the recommendations presented here are needed, we have identified our core asks 
as those which we believe will be most impactful and are required most urgently. The full list 
of policy recommendations is presented in Appendix 4.  
 
To better support staff and research infrastructure:  
 
• In-line with the Academy of Medical Sciences' proposals, the UK Government and 
Devolved Administrations should implement fully funded pilot programmes that offer a 
proportion of health service staff (including those in under-represented professions) 
contracts that include dedicated time for research. 
• The UK Government and Devolved Administrations should uplift long-term funding for 
the NIHR, CSO, HCRW and HSC R&D. At a minimum, these funding increases should be 
in-line with broader uplifts in public R&D investment and keep pace with future 
increases in inflation. 
• NHS Trusts and Health Boards should increase the visibility and accessibility of 
dedicated time for research in order to expand research engagement amongst staff, 
especially under-represented professions. Progress towards this goal should be locally 
monitored using the research metrics and reviews we also recommend, as well as 
periodically reviewed by national NHS bodies. 
 
To target disparities in research activity and capacity:  
 
• The UK Government should conduct a regional review of clinical research activity. The 
review's findings should inform proposals for additional funding that facilitates 
increased research engagement within regions currently under-served by research. The 
review's findings should also inform revisions to existing R&D investment, with a view 
to making this investment more regionally equitable and unlocking research capacity. 
• Local NHS R&D Offices and Human Resources departments should collaboratively 
consult under-represented professions to identify and address the social and cultural 
barriers they face to engaging with research. Progress towards this goal should be 
locally monitored using the research metrics and reviews we also recommend, as well 





To develop pathways for getting into research: 
 
• The NIHR, CSO and HSC R&D should develop new programmes modelled on the HCRW's 
Pathway to Portfolio Development Funding Scheme to fund small-scale projects that 
develop the confidence, expertise and capacity of NHS staff to deliver research. 
• NHS Trusts and Health Boards should embed research into their strategies for staff 
recruitment and retention, and workforce development planning. These local efforts 
should be reinforced by ambitious national strategies for supporting clinical research 
that recognise the NHS as an indispensable part of the UK’s research environment. 
 
To strengthen national- and organisational-level research culture:  
 
• All four national departments of health should develop a coordinated set of metrics to 
capture NHS research engagement and impact. These quantitative metrics should 
capture research's impact on patients, staff, NHS systems and cost savings. The resulting 
data should be incorporated into existing platforms for evaluating NHS Trusts and 
Health Boards. 
• Local NHS R&D Offices should undertake periodic reviews of research awareness and 
activity amongst their health service staff and patients. The resulting qualitative insights 


























Appendix 1 Study design and methods  
Appendix 2 Coding framework for work-package one and work-package three 
interviews 
Appendix 3 Coding framework for work package four (case study) interviews 





This was a mixed methods study comprising of five inter-linked work packages (Figure 1.1) 
and worked iteratively in partnership with CRUK and other key stakeholders to address the 
key research objectives to ensure that they were achieved. Our approach involved collecting 
primary and secondary data from a diverse group of sources, national and local 
organisational stakeholders and people who work in different areas of health research and 
practice.  We adopted qualitative and quantitative data collection methods split between a 
scoping review, key informant interviews, case studies and a structured survey.92,93 This 
approach provided broad stakeholder perspectives. 
We initially undertook a scoping review of the extant literature, interviews with UK-wide key 
stakeholders and interviews with research support staff in NHS organisations. We 
conducted an online questionnaire survey of a wide range of staff in NHS Trusts/Health 
Boards of varying size, university and non-university linked, acute and community and 
geographically spread across the UK. We then conducted case studies involving interviews 
with staff in health care providers.  We obtained ethics approval for the study from the 
University of Kent. 
Our original research proposal included a phased approach to data collection involving 
national and local stakeholders, research evidence, secondary data on research activity and 
research active and non-research active health service staff in local NHS hospital and 
community Trusts/Health Boards. 
We adopted this approach to examine health service staff research engagement and how 
this can be supported and sustained at the micro (individual staff researcher), meso 
(organisational) and macro (system/policy) levels.   
 
At the micro level we wanted to identify what facilitated greater individual involvement in 
research. Key questions included:  
• How are research priorities and questions arrived at?  
• Who delivers the research and advocates for the patients?   
• Who does/could develop research?   
• How is/can clinical research be made a career pathway of choice?   
• How can we ensure the quality and skill set of our future research workforce?   
 
At the meso organisational level we sought to understand the way organisations did or 
could support greater staff involvement in research:  
• What strategies do organisations use to support staff research?  
• Are there effective models for embedding research in health care organisations?  
• What support do organisations need to increase staff engagement in research?  




At a macro system level, the key questions included:  
• What national NHS strategies can support staff engagement in research?  
• What strategies can/do funding organisations pursue to support health service staff 
engagement in research?  
• How can the public influence staff engagement in research?  
 
The research programme was split into five work-packages shown in Figure 1.1 and 
described below.  We made two revisions to our original research proposal. The first was to 
delay the survey in WP3 until after we had conducted the interviews with the key 
stakeholders. This was so that we could use data from the interviews to help design the 
questionnaire survey. The second revision was to WP5 which we had to revise due to the 
COVID-19 crisis. Both revisions were agreed with the Steering Group and approved by the 
University of Kent ethics committee. 
 
Figure 3: Study work packages 
 
Work-package one: Scoping review of the evidence and knowledge on research engagement 
support in health care organisations. 
We undertook a scoping review94,95 of the evidence and knowledge on research engagement 
support in health care organisations. The aim was to identify the current extent of knowledge 
about initiatives/interventions/policies that support successful research engagement. The 
main objectives were:  
1. To map the range and type of initiatives.  
2. To scope the literature on supporting research engagement by health service 
staff and identify gaps in the evidence base.  
We undertook a rapid literature review of the extant literature and conducted scoping 
interviews with 12 key informants from national funding and professional agencies and NHS 
Trusts/Health Boards. For the interviews we adopted a semi-structured with questions 
designed to identify key issues related to supporting increased practitioner engagement in 
research and identify any relevant reports or published literature. Interviewees were asked 
about their involvement in supporting research capacity, views on what was successful or not 
successful and personal ideas about how health service staff could be supported to become 
more involved in research. For the literature review we focused on literature and evidence that 
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highlighted potential practice and policy solutions in the UK and other high-income countries 
that examined supporting health service staff engagement in research.  
For the scoping review we did not undertake a systematic review but rather sought to explore 
areas of current knowledge and evidence. An initial scan of the published literature identified 
two comprehensive reviews by Cooke et al (2018)96 and Huber et al (2015)97 and a report by 
RAND for The Healthcare Improvement Studies Institute.98 The aim was to identify potential 
initiatives for increasing and supporting health service staff engagement in research activities 
so we were primarily interested in examples of interventions, strategies and policies, including 
any evidence of effectiveness if available.  
These were then supplemented with additional papers published from 2015 onwards that 
would not be included in the Cooke et al and Huber et al reviews. We searched MEDLINE and 
Web of Science for grey literature (reports, policy documents etc.). We used key terms drawn 
from the existing reviews (including research capacity, career development, researcher 
development, research engagement AND human resources). We also identified examples of 
initiatives in other countries where relevant to the UK context. The papers and reports 
consulted drew from a diversity of literature ranging from original primary research, evaluation, 
local studies, systematic reviews, measurement and survey tool validation and a study protocol. 
As the aim was not to assess the effectiveness of any strategy or intervention but to rather 
inform later stages of the research papers were selected for topic relevance even if 
commentary pieces or editorials. Each paper was reviewed by a research team member with a 
focus on examples of successful initiatives to increase health service staff engagement using 
our framework of micro, meso and macro level initiatives. 
 
Work-package two: Analysis of secondary data on research activity. 
The aim of this work-package was to obtain an overview of research activity by organisation 
and staff group/speciality to help provide a national picture of activity and to help identify 
locations for work-packages three and four. We undertook an analysis of secondary data on 
research activity. We analysed data from the CRN Open Data Platform to identify and compare 
levels of staff research activity across institutions, geographical areas, specialities, health 
service settings and by disease/demographic indicators. We supplemented this with data on 
research funding, academic outputs and workforce data.   
 
Three different data sources were used as measures of health research activity in NHS 
organisations: 
• Clinical Research Network supported studies from the CRN Open Data Platform 
• Health research grants active in 2014 from UK Health Research Analysis (UK Clinical 
Research Collaboration) 
• Clinical and health research fellowships active in 2017 from the UK Wide Survey of Clinical 
and Health Research Fellowships (MRC)  
 
The CRN data showed that out of 506 NHS organisations in the UK, 462 (91%) had CRN 
supported studies in 2018/19. The UK Health Research Analysis dataset identified a total of 155 
NHS organisations that held active health research grants in 2014. From the fellowships dataset 
we identified 44 NHS organisations that held between 1 and 5 active fellowships in 2017. 
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From this analysis we identified a longlist of potential sites. These were presented to the 
Steering Group with the supporting analyses. The Steering Group then selected and agreed the 
case study and survey sites.   
Work-package three: Survey of research active and research non-active staff in health care 
providers. The aim of this work-package was to identify the views of health service staff on 
issues related to what enables them to become more involved in clinical research, with a 
specific focus on what drivers and incentives support research activity and capacity. We 
undertook a survey of health service staff from different professional groups and specialities 
across a number of NHS health care providers. Survey questions were developed based on data 
from interviews with 14 research funder representatives and 25 R&D directors and leads, 
combined with data from Work-package one. The deductive framework approach was applied 
for the analysis of work-packages one and three interviews. It is based upon the development 
of a matrix based method of analysis suited to policy based research in which research 
objectives are pre-determined.71,72 The analysis framework focused on four key areas: 
motivation, challenges, funding, and overall reflections in relation to the engagement and 
capacity of healthcare staff to conduct research (Appendix 2). 
The survey was created using Qualtrics software and consisted of up to 42 questionnaire items 
(the number of questions seen by participants depended on the responses given). The 
questions asked about: 
• current role 
• research engagement and activity 
• motivations, enablers and barriers to research activity 
• organisational support for research activities 
• strategic questions for senior level staff.   
 
The survey was piloted with NHS staff from community and acute Trusts. 
The CRUK online survey was launched in November 2019 and staff members of 11 diverse NHS 
health care providers were invited to complete it. Participating NHS organisations included 
seven English Trusts (five Acute Trusts, one Community Trust and one Mental Health Trust), 
two Scottish Regional NHS Health Boards, a Welsh Local Health Board and a Northern Ireland 
Health & Social Care Trust. Survey locations were selected in discussion between the research 
team and the Steering Group. The survey locations varied in size with staff headcounts from 
4,600 to over 24,000. Research activity within Trusts/Health Boards ranged from low (<28 
Clinical Research Network (CRN) supported studies in 2018/19) to very high (>1100 CRN 
supported studies in the same year).  
We closed the survey on 9th April 2020 for analysis with 1235 responses made by that date. Of 
these 1,016 responses were included for analysis after exclusions, with 805 being fully 
completed and 292 completed at least 30% (see Supplementary Survey Report for details). 
Three quarters (n=751) of responses were from English Trusts (who made up 45% of 
participating organisations) with 11% (n=112) from Scottish Health Boards, 10% (n=106) from 
Welsh Health Boards and 4% (n=47) from Northern Ireland. In England over 80% of responses 
were from acute Trusts with 19% from Community/Mental Health Trusts. Of those responding, 
86% were qualified healthcare professionals and 51.5% had reported postgraduate research 
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training (See Figure 1.2).  
 
Figure 1.2 Role of survey participants 
 
In addition to responding to survey questions we analysed 181 open text responses using the 
same coding framework used for WP3 interviews (Appendix 2). This data has been incorporated 
into the qualitative data analysis in WP4. 
 
Work-package four: Case study research in selected health care providers. The aim of this 
work-package was to gain an in-depth understanding of the context at an individual and 
organisational level of initiatives to support health service staff engagement in research 
activities. We adopted a multi-site case study methodology to provide an in-depth exploratory 
and explanatory analysis.69 We interviewed 51 staff in six NHS organisations in four countries 
(3 in England, 1 in Wales, 1 in Scotland and 1 in Northern Ireland.  Case study sites represented 
a mix of locations, specialities/staff groups and disease areas.  The Study sites are shown in 
Table 1.1. 
In each case study we interviewed and audio recorded interviews with key research support 
staff, active and inactive researchers/potential researchers, senior managers, other local 
research stakeholders (e.g. RDS, CRN), health service staff in different roles and staff on 
research development programmes (e.g. ICAPs/PCAFs). Data was coded with NVivo and 
thematically analysed.73,74 Through thematic analysis, we examined the interviewees’ 
viewpoints and compared them for cross case themes, drawing out the policy initiatives and 






Table 1.1: Work-package 4 case study sites 










of staff  
Type of Trust Number of 
interviewees 
Guy’s and St 
Thomas’ NHS 
Foundation Trust  















Foundation Trust  
South 
East 


















Health and Social 
Care Trust  
N Ireland  42 5  10,217 NI Integrated 
Trust  
6 
a. Source: NIHR CRN Open Data Platform, 2018/19 
Work-package five: Assessment and prioritisation of interventions.70 The aim of this phase of 
the research was to assess actions identified in the course of the research that potentially could 
increase health service staff involvement in research. Key initiatives identified from interviews 
and survey responses as well as from the scoping study were extracted. We planned to use a 
structured RAND/UCLA approach to evaluate and prioritise these initiatives and develop policy 
and practice initiatives that are considered viable and sustainable for supporting greater health 
services staff involvement in research.70 This was to involve two rounds of prioritisation by 
“experts” - the first online individual assessments and then a face-to-face prioritisation panel. 
However, during the first stage of initiative evaluation the NHS was beginning to respond to 
the COVID-19 pandemic. While we had recruited a panel of over 20 “experts” (drawn from 
national agencies, funders, industry and local health care providers) to review suggested 
initiatives identified from our survey and interviews, many people were unable to complete the 
exercise. It was also intended to hold a second “expert” group to undertake the priority and 
feasibility assessment from which to draw up a list of policy recommendations.  
This was not possible and instead we held a meeting of the Steering Group to discuss the full 
list of initiatives drawn from our findings and provide guidance on priority. The research team 
then revised a list of initiatives and these were subsequently reviewed again by the Steering 





Themes Key topics 
Motivations What motivates a healthcare professional to undertake research? 
How does research fit with their clinical work in the NHS? 
How does your organisation Support / Attract healthcare professionals who 
decide to undertake research as part of their career 
Added value to NHS organisation if healthcare professionals become more 
research active? 
How does your organisation use and value research activities by healthcare 
professionals? 
Challenges key challenges for HCPs want to be more research active 
How could an NHS organisation enable HCP to address the challenges? 
What activities does your organisation do to support research active 
professionals? 
What knowledge and skills provisions are made by your organisation for staff 
to conduct research? 
What additional resources and knowledge do you think your organisation 
needs? 
How can your organisation influence change to ensure that HCP are well 
supported to be research active? 
Funding How is the funding linked to the employment contract of HCPs? 
How does the funding support research costs as well as clinical time? 
Changes to the funding model 
examples of good practice for funding from other countries/organisations 
Overall 
reflections 
Overall value of promoting and funding research engagement? 
Do you have research development as a main strategic priority within your 
overall organisational strategy? 
How does your organisation evaluate the impact of HCPs' engagement in 
research? 
Will your organisation continue to fund/train HCPs to engage in research 
activities over the next 10 years? 
What will success look like? 
What are the main factors that individuals, organisation, funders/regulators 




Motivations Organisational culture, expectations, requirements, benefits 
Patients experience and outcomes 
Personal interests / development 
Challenges Time & workload 
Opportunities for practical support not clearly communicated  
Communicating with and recruiting patients 
Lack of (awareness of) formal or informal routes to progress research  
Culture and leadership – focusing on service delivery instead of research; 
insufficient support from middle management and board levels 
Funding (individual, professional, department or directorate differences) 
Inequalities (between roles, specialties, regions, settings) 
Insufficient staff for clinical & research work 
Lack of confidence and awareness of support options 
Lack of different pathways into research 
Research skills capacity in team/department 
Wider health and social care context 
Funding Availability of funding or schemes 
Job contract & payment 
Mechanisms of funding allocation 
Examples of good practice for funding 
Strategic 
reflections 
Embed, promote and celebrate research success 
Organisational or universal approach to support staff to undertake research 
Organisational awareness  
Research as strategy on paper but not turn into action, or not priority 
compared to clinical and other strategies 
Recommendations 
& Solutions 
Macro level Recommendations 
Meso level Recommendations 







We recommend DHSC and the Devolved Administrations should be given responsibility for 
ensuring this report's recommendations are implemented as an integrated package of policy 
solutions to the systemic challenges afflicting NHS research.  
 
1. NHS Trusts and Health Boards should increase the visibility and accessibility of 
dedicated time for research in order to expand research engagement amongst staff, 
especially under-represented professions. Progress towards this goal should be locally 
monitored using the research metrics and reviews we also recommend, as well as 
periodically reviewed by national NHS bodies. 
2. In-line with the Academy of Medical Sciences' proposals, the UK Government and 
Devolved Administrations should implement fully funded pilot programmes that offer a 
proportion of health service staff (including those in under-represented professions) 
contracts that include dedicated time for research. 
3. The UK Government and Devolved Administrations should uplift long-term funding for 
the NIHR, CSO, HCRW and HSC R&D. At a minimum, these funding increases should be 
in-line with broader uplifts in public R&D investment and keep pace with future 
increases in inflation. 
 
4. The UK Government should conduct a regional review of clinical research activity. The 
review's findings should inform proposals for additional funding that facilitates 
increased research engagement within regions currently under-served by research. The 
review's findings should also inform revisions to existing R&D investment, with a view 
to making this investment more regionally equitable and unlocking research capacity. 
5. National and local research funders should increase the funding that is targeted towards 
under-represented professions. This should include increasing the number of 
structured opportunities for these professions to participate in research (e.g. Clinical 
Studies Groups and NIHR Specialty Clusters focusing more on involving under-
represented professions).  
6. Local NHS R&D Offices and Human Resources departments should collaboratively 
consult under-represented professions to identify and address the social and cultural 
barriers they face to engaging with research. Progress towards this goal should be 
locally monitored using the research metrics and reviews we also recommend, as well 
as periodically reviewed by national NHS bodies. 
7. The UK Government and Devolved Administrations should invest more in under-served 
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specialties and engage with their networks (e.g. CSGs) to identify opportunities to 
unlock research capacity. 
 
8. The NIHR, CSO and HSC R&D should develop new programmes modelled on the HCRW's 
Pathway to Portfolio Development Funding Scheme to fund small-scale projects that 
develop the confidence, expertise and capacity of NHS staff to deliver research. 
9. Local NHS R&D Offices, with support from their NHS organisations, should establish 
mentorship programmes that pair prospective researchers with established 
researchers. These programmes should be available to all health service staff and be 
designed to support staff's professional development and engagement with research. 
10. The onboarding process for all NHS staff should include an induction on their 
Trust/Health Board's research strategy, how it is being operationalised (e.g. research 
time applications, funding opportunities, secondments, etc.), and the role staff can play 
in delivering that strategy. 
11. NHS Trusts and Health Boards should embed research into their strategies for staff 
recruitment and retention, and workforce development planning. These local efforts 
should be reinforced by ambitious national strategies for supporting clinical research 
that recognise the NHS as an indispensable part of the UK’s research environment. 
 
12. All four national departments of health should develop a coordinated set of metrics to 
capture NHS research engagement and impact. These quantitative metrics should 
capture research's impact on patients, staff, NHS systems and cost savings. The resulting 
data should be incorporated into existing platforms for evaluating NHS Trusts and 
Health Boards. 
13. Local NHS R&D Offices should undertake periodic reviews of research awareness and 
activity amongst their health service staff and patients. The resulting qualitative insights 
should inform local efforts to showcase research's value and increase staff engagement 
with research. 
14. Local NHS R&D Offices and universities should establish integrated research offices in 
order to facilitate the exchange of research expertise and build research capacity. These 
integrated research offices should be responsible for the local implementation of our 
recommendations (below) to increase formal opportunities for inter-profession 
learning. 
15. NHS Trusts and Health Boards and local universities should increase the number of 
formal opportunities available to their staff to work in academic/clinical settings. These 
secondments should formally focus on building research capacity and be available to all 
health service staff. 
16. Universities should increase the number of opportunities for students (across all health 
service professions) to undertake research projects in clinical settings. These projects 
should formally focus on developing students understanding of the exchange between 
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research and clinical practice. 
17. Local NHS R&D Offices should frequently showcase and promote their research using 
events, reading groups, consultations and other active methods of engagement in order 
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